CAPILLARY — Capillary Technologies India Balance Sheet
0.000.00%
- IN₹41.84bn
- IN₹37.44bn
- IN₹7.35bn
Annual balance sheet for Capillary Technologies India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 300 | 471 | 2,518 | 2,153 | 4,930 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 708 | 958 | 1,996 | 1,759 | 1,808 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,082 | 1,498 | 4,652 | 4,182 | 7,210 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 61.3 | 40.6 | 61.3 | 94.1 | 120 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 3,475 | 4,664 | 8,711 | 8,387 | 13,002 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,905 | 2,241 | 3,092 | 2,507 | 2,574 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 2,313 | 2,798 | 3,321 | 2,704 | 2,767 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 1,161 | 1,866 | 5,390 | 5,682 | 10,235 |
| Total Liabilities & Shareholders' Equity | 3,475 | 4,664 | 8,711 | 8,387 | 13,002 |
| Total Common Shares Outstanding |